HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Otorhinolaryngologic Diseases

Subscribe to New Research on Otorhinolaryngologic Diseases

Pathological processes of the ear, the nose, and the throat, also known as the ENT diseases.

Also Known As:

ENT Diseases; Otolaryngological Diseases; Otorhinolaryngologic Disease; Otorhinolaryngological Disease; Disease, ENT; Disease, Otolaryngologic; Disease, Otolaryngological; Disease, Otorhinolaryngologic; Disease, Otorhinolaryngological; Diseases, ENT; Diseases, Otolaryngologic; Diseases, Otolaryngological; Diseases, Otorhinolaryngologic; Diseases, Otorhinolaryngological; ENT Disease; Otolaryngologic Disease; Otolaryngological Disease; Otorhinolaryngological Diseases; Otolaryngologic Diseases

Networked: 130 relevant articles (5 outcomes, 6 trials/studies)

Relationship Network

Disease Context: Research Results

Otorhinolaryngologic Diseases: 130

Related Diseases

1.	Pain (Aches)
2.	Respiratory Tract Infections (Respiratory Tract Infection)
3.	Osteoarthritis
4.	Inflammation
5.	Fever (Fevers)

Experts

1.	Pal'chun, V T: 2 articles (01/2005 - 01/2004)
2.	Kunel'skaia, N L: 2 articles (01/2005 - 01/2004)
3.	Amoroso, Cinzia: 1 article (05/2015)
4.	Berardini, Marco: 1 article (05/2015)
5.	Falco, Antonello: 1 article (05/2015)
6.	D'Archivio, Lanfranco: 1 article (05/2015)
7.	Takano, Kenichi: 1 article (12/2014)
8.	Takahashi, Yuki: 1 article (12/2014)
9.	Yamamoto, Motohisa: 1 article (12/2014)
10.	Abe, Ayumi: 1 article (12/2014)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Otorhinolaryngologic Diseases:

1.	Carbon MonoxideIBA 01/01/1999 - "Oral co-amoxiclavs proved highly effective in ENT diseases in children and are superior to intramuscular ampicilline." 01/01/2013 - "The widespread application of these phenomena gives evidence of their universal biological nature as factors involved in the interactions between the organism and pathogens (including co-morbidity), the process leading to the enhancement of non-specific resistance, mechanisms underlying realization of pharmacodynamic effects of a number of pharmaceutical products,etc. The understanding of the protective potential of PreC and PostC dictates the necessity to revise and further elaborate the present-day strategy of prophylaxis and treatment of the most serious chronic ENT diseases."
2.	nimesulide (Aulin)IBA 01/01/2002 - "[Nimesulide (Aulin)--the selective COX-2 inhibitor in the treatment of ENT diseases]." 12/01/1988 - "Although still at an early stage of clinical assessment, preliminary evidence suggests that nimesulide 200 to 400mg daily is significantly more effective than placebo in reducing the pain, fever and inflammatory symptoms of chronic rheumatoid arthritis or osteoarthritis, respiratory tract infections, otorhinolaryngological diseases, soft tissue and oral cavity inflammation, dysmenorrhoea, phlebitis/thrombosis, urogenital disease and postoperative pain states. " 12/01/1988 - "In a number of comparative studies, nimesulide has also been shown to be more effective than piroxicam (in osteoarthritis), paracetamol (acetaminophen) [in respiratory tract inflammation], benzydamine or naproxen (in otorhinolaryngological disease), phenylprenazone (in laryngotracheitis/bronchitis, respiratory inflammation and otorhinolaryngological disease), Serratia peptidases (in postoperative or dental pain, trauma and phlebitis), ketoprofen (in postoperative dental pain) and mefenamic acid (in dysmenorrhoea). "
3.	moxifloxacin (Avelox)FDA Link 01/01/2005 - "The comparison of the efficacy of a number of antibacterial drugs in acute pyoinflammatory ENT diseases allowed the authors to recommend moxifloxacin as most effective in acute purulent ENT pathology. "
4.	Ketoprofen (Orudis)FDA LinkGeneric 09/01/1996 - "Open label, non-controlled study of ketoprofen 25 mg tablets in the treatment of pain in ENT diseases, dysmenorrhoea, and musculoskeletal disorders. " 12/01/1988 - "In a number of comparative studies, nimesulide has also been shown to be more effective than piroxicam (in osteoarthritis), paracetamol (acetaminophen) [in respiratory tract inflammation], benzydamine or naproxen (in otorhinolaryngological disease), phenylprenazone (in laryngotracheitis/bronchitis, respiratory inflammation and otorhinolaryngological disease), Serratia peptidases (in postoperative or dental pain, trauma and phlebitis), ketoprofen (in postoperative dental pain) and mefenamic acid (in dysmenorrhoea). "
5.	Tranexamic Acid (AMCA)FDA Link 02/15/1981 - "[Controlled clinical study of tranexamic acid in the treatment of inflammatory otorhinolaryngological diseases]."
6.	TabletsIBA 09/01/1996 - "Open label, non-controlled study of ketoprofen 25 mg tablets in the treatment of pain in ENT diseases, dysmenorrhoea, and musculoskeletal disorders. "
7.	Procainamide (Procan)FDA LinkGeneric 01/01/1953 - "[Study of 40 cases of otorhinolaryngological diseases treated by procaine amide]."
8.	Carticaine (Articaine)IBA 11/01/1996 - "The results of ultracaine trial are available for 136 patients with ENT diseases. "
9.	beta-Lactamases (beta-Lactamase)IBA 01/01/1996 - "To study the bacterial flora in the upper respiratory tract we examined bacteria obtained from the larynx, posterior pharyngeal wall, palatine tonsil and nasal cavity to identify the constitutent strains and check for the existence of beta-lactamase in 37 subjects without infectious otolaryngological disease who underwent surgery with general anesthesia. "
10.	Anti-Bacterial Agents (Antibiotics)IBA 05/01/2012 - "Failure of antibiotics to eradicate the microbial pathogens primarily responsible for otorhinolaryngological diseases has led to the hypothesis that these microorganisms may be structured in a biolfilm. " 01/01/2007 - "The antibiotics could be recommended for the treatment of otorhinolaryngologic diseases." 02/01/1989 - "[Effect of antibiotics on the antiviral resistance of the body in chronic ENT diseases]." 11/01/1981 - "[Sensitivity to antibiotics and staphylococcal phages isolated in ENT diseases]." 09/15/1956 - "[Treatment of otorhinolaryngological diseases with antibiotics]."

Therapies and Procedures

1.	Oral Surgery (Maxillofacial Surgery) 09/01/1994 - "In mostly short term studies (up to 4 weeks), it was effective in reducing pain associated with osteoarthritis, cancer, thrombophlebitis, oral surgery and dysmenorrhoea in adults, reducing pain associated with general surgery in adults and children, and pain, fever and inflammation accompanying respiratory tract infections, otorhinolaryngological diseases and traumatic injury in adults and children. "
2.	Tissue Therapy (Cell Therapy) 03/01/1952 - "[Efficacy of tissue therapy in otolaryngological diseases]." 03/01/1953 - "[Tissue therapy of certain otolaryngological diseases]." 01/01/1953 - "[Tissue therapy in certain otolaryngological diseases]." 03/01/1952 - "[Results of tissue therapy in polyclinic in certain otolaryngological diseases]."
3.	General Anesthesia 01/01/1996 - "To study the bacterial flora in the upper respiratory tract we examined bacteria obtained from the larynx, posterior pharyngeal wall, palatine tonsil and nasal cavity to identify the constitutent strains and check for the existence of beta-lactamase in 37 subjects without infectious otolaryngological disease who underwent surgery with general anesthesia. "
4.	Laser Therapy (Surgery, Laser) 01/01/2001 - "Laser therapy was given to 75 patients with different ENT diseases with good effect. " 10/20/1991 - "[Laser surgery in otorhinolaryngologic diseases]."
5.	Injections 01/01/2002 - "Treatment of hypersalivation by local injections of Botox into the salivary glands of the head is a reliable and efficient therapy without side effects for certain otolaryngological diseases, especially if injections are performed under sonographic control. " 10/01/1986 - "Submucosal injections of teflon paste (suspension of teflon in glycerin) are used for therapy of ENT diseases. "